Key terms
About FMS
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest FMS news
Mar 05
10:00am ET
Fresenius Medical rises 10.2%
Mar 05
9:47am ET
Fresenius Medical rises 9.5%
Feb 23
2:30pm ET
Fresenius Medical price target raised to EUR 34 from EUR 33 at Morgan Stanley
Feb 22
3:10pm ET
Fresenius Medical price target raised to EUR 35.40 from EUR 33 at JPMorgan
Feb 21
1:02am ET
A New Cause for Concern: Fresenius Medical Care Adds a New International Operations Risk
Jan 31
2:33pm ET
Fresenius Medical price target raised to EUR 33 from EUR 28 at JPMorgan
Jan 17
7:01am ET
Fresenius Medical reinstated with an Underperform at BofA
Jan 08
4:38am ET
Fresenius Medical downgraded to Underweight from Equal Weight at Morgan Stanley
No recent press releases are available for FMS
FMS Financials
Key terms
Ad Feedback
FMS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FMS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
